Repella Robert 4
4 · Biohaven Pharmaceutical Holding Co Ltd. · Filed Sep 11, 2018
Insider Transaction Report
Form 4
Repella Robert
Director
Transactions
- Award
Stock Option (right to buy)
2018-09-07+36,000→ 36,000 totalExercise: $35.50Exp: 2028-09-06→ Common Shares (36,000 underlying)
Footnotes (1)
- [F1]This option grant was made pursuant to the issuer's non-employee director compensation policy. The common shares underlying this option vest in three equal installments on September 7, 2019, 2020 and 2021, subject to the reporting person's continuous service with the issuer at each vesting date.